CRT 2025
Endovascular
Hot Topics in Endovascular Interventions Sunday
Nelson L. Bernardo, MD, FSCAI
Medical Director
MedStar Heart and Vascular Institute at MedStar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure information not submitted.
Steve D. Abramowitz, MD
Chair, Vascular Surgery
MedStar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure information not submitted.
Herbert D. Aronow, MD, MPH
Medical Director, Heart & Vascular Services
Henry Ford Health
Detroit, Michigan, United States
Disclosure(s): Amplitude Vascular Systems: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Terminated); Rapid AI: Consultant (Ongoing)
James Stephen Jenkins, MD
Section Head, Interventional Cardiology
Director, Interventional Cardiology Research
Ochsner Medical Center
New Orleans, Louisiana, United States
Disclosure(s): Abbott Labs: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Wei Zhou, MD
Professor and Chief of Vascular Surgery
University of Arizona
Tucson , Arizona, United States
Disclosure information not submitted.
Gholam Ali, MD, FACC, FSVM,FNLA
Medical Director of Vascular Lab
Tulane University Heart and Vascular Institute
New Orleans, Louisiana, United States
Disclosure information not submitted.
John Fritz Angle, MD
Professor of Radiology
University of Virginia
Charlottesville, Virginia, United States
Disclosure(s): EndoRon Ltd: Consulting Fees (e.g., advisory boards) (Ongoing)
J. Michael Bacharach, MD
Section Head, Vascular Medicine and Peripheral Vascular Intervention
North Central Heart Institute
Sioux Falls, South Dakota, United States
Disclosure information not submitted.
Schuyler Jones, MD
Associate Professor of Medicine
Duke University Medical Center
Durham, North Carolina, United States
Disclosure information not submitted.
Ankur Lodha, MD
Interventional Cardiologist
Cardiovascular Institute of the South
Lafayette, Louisiana, United States
Disclosure information not submitted.
D. Christopher Metzger, MD, FSCAI, FACC
Interventional Cardiologist
Ballad CVA Heart and Vascular Institute
Kingsport, Tennessee, United States
Disclosure information not submitted.
Horst Sievert, MD, FSCAI, FACC, FESC
Director
CardioVascular Center Frankfurt CVC
Frankfurt, Hessen, Germany
Disclosure(s): Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Bioventrix, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, K2, Laminar, Lifetech: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Magenta, Maquet Getinge Group, Metavention, Mitralix, Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria to institution, travel expenses, consulting fees (Ongoing)
Michael Wholey, MD, MBA, FSCAI
Interventional Radiology
University Texas San Antonio
San Antonio, Texas, United States
Disclosure(s): No financial relationships to disclose
James P. Zidar, MD, FSCAI
Clinical Professor of Medicine
University of North Carolina/Rex Healthcare
Raleigh, North Carolina, United States
Disclosure(s): CONTEGO MEDICAL: Consulting Fees (e.g., advisory boards) (Ongoing)